How to choose a compounded GLP-1 pharmacy

Begin with the legal name, physical address, phone number, and dispensing role of the pharmacy. A telehealth platform and a pharmacy are different entities. Knowing the platform’s name is not enough if you cannot identify who actually prepares and dispenses the medication.

Ask whether a licensed clinician reviews your medical history and issues an individual prescription when appropriate. Join Luma states that a licensed clinician reviews every intake and patients are charged only if treatment is approved. That describes the care process; it does not eliminate the need to confirm the dispensing pharmacy or make a compounded medication FDA-approved.

For background, the FDA compounding questions and answers explains the distinction between an approved drug and a compounded preparation. Use that distinction throughout your comparison. Claims that a compound is an FDA-approved generic, identical to a branded product, or guaranteed to produce a particular outcome deserve closer scrutiny.

Search the official state board database, not just the pharmacy’s own website. Match the exact legal name, address, and license number, then check whether the credential is active and whether the category fits the work described. A license belonging to a different branch or a similarly named business does not verify your dispenser.

For VialsRx, begin with the Texas State Board of Pharmacy search and the supplied license number 35264. Hallandale’s supplied Florida number is PH28017. Also ask about authorization to ship into your state: home-state licensing and permission to serve your address are related but separate checks.

If a database result is unclear, contact the board or pharmacist rather than guessing. Public inspection records and disciplinary orders can require context. Check dates, the substance of any finding, and the response; absence of a prominent warning on a commercial page is not the same as an official current record.

Injectable preparations must be sterile. Verify that the pharmacy holds the applicable sterile compounding authorization rather than assuming that any pharmacy license covers every preparation. State categories differ, so ask the board what the specific permit allows. Florida’s nonresident sterile compounding permit information illustrates how shipping and sterile work can involve additional state requirements.

USP General Chapter 797 addresses sterile compounding standards. These involve more than wearing gloves: preparation environments, personnel practices, quality controls, and beyond-use dating are relevant questions. Ask how the pharmacy applies the standards and what instructions it supplies for handling your vial.

For oral or other nonsterile preparations, USP 795 is the relevant general chapter rather than treating every compounded product as a sterile injection. Standards and applicable law work together; a statement about USP does not replace checking the actual state authorization.

Inspection reports can help you understand what regulators observed at a particular time. Look for the date, scope, findings, corrective actions, and any later follow-up. Zero deficiencies at a past inspection is useful historical information, not a guarantee about every future preparation.

PCAB accreditation is a separate voluntary credential. Ask whether it is current, which location it covers, and whether its scope includes the type of compounding you need. Accreditation supplements your review; it does not substitute for a license or turn a compounded medication into an FDA-approved drug.

API means active pharmaceutical ingredient. Ask the pharmacy whether its API comes from an FDA-registered establishment and what documentation it uses to verify identity and quality. Under the 503A framework, bulk-substance sourcing and applicable quality requirements matter. Supplier registration is only one part of the picture, not FDA approval of the ingredient shipment or finished preparation.

The FDA GLP-1 concerns page distinguishes semaglutide base from semaglutide sodium and semaglutide acetate. Ask which ingredient is used rather than assuming the word semaglutide answers the question. Do not buy products labeled for research use only or not for human consumption for self-injection.

Also ask what other ingredients are present and why they were chosen. Glycine or vitamin B12 does not automatically establish a clinical advantage or a legal exception. The prescriber should assess your individual needs; marketing language about customization should not replace that discussion.

Join Luma identifies Hallandale as a Florida licensed 503A pharmacy with Special Sterile Compounding License PH28017. Hallandale prepares the additive-free formulation and reports PCAB accreditation. Its service area covers 41 states, excluding Alabama, Arkansas, California, Hawaii, Kansas, Massachusetts, Michigan, Minnesota, and Mississippi.

VialsRx is identified as a Texas licensed 503A pharmacy, license 35264, Class A-S sterile compounding. It prepares the glycine or vitamin B12 formulation and serves all 50 states. The supplied partner information reports zero deficiencies in February 2025 and March 2026 inspections. Readers should request current documentation rather than treating these supplied details as a fresh independent audit.

The brief does not provide partner-specific API registration records, certificates of analysis, or full inspection reports. This article therefore does not assert that those records were independently reviewed. Ask the pharmacies for sourcing and quality documentation if you need it. Compare the Hallandale profile and VialsRx profile with official records.

Be cautious if there is no prescription requirement, no identifiable dispensing pharmacy, unclear ingredient identity, missing directions, or a research-use disclaimer. Another red flag is a promise that an additive makes every prescription legal. The end of GLP-1 shortage-related transition periods means the specific prescribing and compounding conditions remain important.

Your vial should name the pharmacy and list concentration, directions, and beyond-use date. If the instructions conflict, do not improvise. Read how to identify your pharmacy and the 503A versus 503B guide to separate practical dispensing checks from regulatory terminology.

For Join Luma questions, contact support@joinluma.com or use the patient portal. A good selection process leaves you knowing who prescribed, who prepared the medication, and who can resolve a question before the next dose. See the partner overview to begin that conversation.